Relative bioavailability and comparative clinical efficacy of different ivermectin oral formulations in lambs

Autores
Suarez, Gonzalo; Alvarez, Luis Ignacio; Castells, Daniel; Correa, Oscar; Figiolino, Pietro; Lanusse, Carlos Edmundo
Año de publicación
2013
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Several oral ivermectin (IVM) formulations for use in sheep are available in the pharmaceutical veterinary market in different countries. All of them are indicated at the same dose rate to treat the gastrointestinal nematodes. However, there is a lack of information on the relative systemic exposure (plasma bioavailability) and clinical efficacy among oral formulations routinely used in sheep. The main goal of the work reported here was to perform a pharmaco-parasitological assessment of three different IVM oral formulations in lambs infected with multiple resistant gastrointestinal nematodes. The comparative drug systemic exposure (IVM plasma concentrations) and nematodicidal efficacies (clinical efficacy) in lambs were determined for a reference (RF) and two different test (T1, T2) IVM oral formulations. One hundred and fifty six (n= 156) healthy Corriedale lambs, naturally infected with multiple resistant gastrointestinal nematodes were allocated into four experimental groups (n=39). Animals in each group received treatment (200 μg/kg) with either the RF, one of the test IVM formulations or were kept as untreated control. Blood samples were collected over 15 days post-treatment (n=8). The IVM plasma concentrations were measured by high performance liquid chromatography with fluorescence detection. The faecal nematode egg count reduction test (FECRT) and evaluation of the clinical efficacy were performed at day 14 post-treatment (n=6), where a predominance of IVM highly resistant nematodes was observed. Results and conclusions Neither the overall kinetic behaviour nor the IVM systemic exposure differed among all the tested oral formulations. Equivalent efficacy results were obtained for the different preparations, with an evident therapeutic failure to control Haemonchus spp. and Teladorsagia circumcincta, which correlates with a high degree of nematode resistance to IVM.
Fil: Suarez, Gonzalo. Universidad de la Republica; Uruguay;
Fil: Alvarez, Luis Ignacio. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico - CONICET - Tandil. Centro de Investigación Veterinaria de Tandil; Argentina;
Fil: Castells, Daniel. Área de Investigación del Secretariado Uruguayo de la Lana; Uruguay;
Fil: Correa, Oscar. Universidad de la Republica; Uruguay;
Fil: Figiolino, Pietro. Universidad de la Republica; Uruguay;
Fil: Lanusse, Carlos Edmundo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico - CONICET - Tandil. Centro de Investigación Veterinaria de Tandil; Argentina;
Materia
Bioavailability
Efficacy
Ivermectin
Lambs
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/1829

id CONICETDig_d922019e887d806e5a9967a42263afc3
oai_identifier_str oai:ri.conicet.gov.ar:11336/1829
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Relative bioavailability and comparative clinical efficacy of different ivermectin oral formulations in lambsSuarez, GonzaloAlvarez, Luis IgnacioCastells, DanielCorrea, OscarFigiolino, PietroLanusse, Carlos EdmundoBioavailabilityEfficacyIvermectinLambshttps://purl.org/becyt/ford/4.3https://purl.org/becyt/ford/4Several oral ivermectin (IVM) formulations for use in sheep are available in the pharmaceutical veterinary market in different countries. All of them are indicated at the same dose rate to treat the gastrointestinal nematodes. However, there is a lack of information on the relative systemic exposure (plasma bioavailability) and clinical efficacy among oral formulations routinely used in sheep. The main goal of the work reported here was to perform a pharmaco-parasitological assessment of three different IVM oral formulations in lambs infected with multiple resistant gastrointestinal nematodes. The comparative drug systemic exposure (IVM plasma concentrations) and nematodicidal efficacies (clinical efficacy) in lambs were determined for a reference (RF) and two different test (T1, T2) IVM oral formulations. One hundred and fifty six (n= 156) healthy Corriedale lambs, naturally infected with multiple resistant gastrointestinal nematodes were allocated into four experimental groups (n=39). Animals in each group received treatment (200 μg/kg) with either the RF, one of the test IVM formulations or were kept as untreated control. Blood samples were collected over 15 days post-treatment (n=8). The IVM plasma concentrations were measured by high performance liquid chromatography with fluorescence detection. The faecal nematode egg count reduction test (FECRT) and evaluation of the clinical efficacy were performed at day 14 post-treatment (n=6), where a predominance of IVM highly resistant nematodes was observed. Results and conclusions Neither the overall kinetic behaviour nor the IVM systemic exposure differed among all the tested oral formulations. Equivalent efficacy results were obtained for the different preparations, with an evident therapeutic failure to control Haemonchus spp. and Teladorsagia circumcincta, which correlates with a high degree of nematode resistance to IVM.Fil: Suarez, Gonzalo. Universidad de la Republica; Uruguay;Fil: Alvarez, Luis Ignacio. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico - CONICET - Tandil. Centro de Investigación Veterinaria de Tandil; Argentina;Fil: Castells, Daniel. Área de Investigación del Secretariado Uruguayo de la Lana; Uruguay;Fil: Correa, Oscar. Universidad de la Republica; Uruguay;Fil: Figiolino, Pietro. Universidad de la Republica; Uruguay;Fil: Lanusse, Carlos Edmundo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico - CONICET - Tandil. Centro de Investigación Veterinaria de Tandil; Argentina;Biomed Central2013-02-11info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/1829Suarez, Gonzalo; Alvarez, Luis Ignacio; Castells, Daniel; Correa, Oscar; Figiolino, Pietro; et al.; Relative bioavailability and comparative clinical efficacy of different ivermectin oral formulations in lambs; Biomed Central; BMC Veterinary Research; 9; 27; 11-2-2013; 1-81746-6148enginfo:eu-repo/semantics/altIdentifier/url/http://www.biomedcentral.com/1746-6148/9/27info:eu-repo/semantics/altIdentifier/url/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599275/info:eu-repo/semantics/altIdentifier/doi/10.1186/1746-6148-9-27info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:57:03Zoai:ri.conicet.gov.ar:11336/1829instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:57:03.888CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Relative bioavailability and comparative clinical efficacy of different ivermectin oral formulations in lambs
title Relative bioavailability and comparative clinical efficacy of different ivermectin oral formulations in lambs
spellingShingle Relative bioavailability and comparative clinical efficacy of different ivermectin oral formulations in lambs
Suarez, Gonzalo
Bioavailability
Efficacy
Ivermectin
Lambs
title_short Relative bioavailability and comparative clinical efficacy of different ivermectin oral formulations in lambs
title_full Relative bioavailability and comparative clinical efficacy of different ivermectin oral formulations in lambs
title_fullStr Relative bioavailability and comparative clinical efficacy of different ivermectin oral formulations in lambs
title_full_unstemmed Relative bioavailability and comparative clinical efficacy of different ivermectin oral formulations in lambs
title_sort Relative bioavailability and comparative clinical efficacy of different ivermectin oral formulations in lambs
dc.creator.none.fl_str_mv Suarez, Gonzalo
Alvarez, Luis Ignacio
Castells, Daniel
Correa, Oscar
Figiolino, Pietro
Lanusse, Carlos Edmundo
author Suarez, Gonzalo
author_facet Suarez, Gonzalo
Alvarez, Luis Ignacio
Castells, Daniel
Correa, Oscar
Figiolino, Pietro
Lanusse, Carlos Edmundo
author_role author
author2 Alvarez, Luis Ignacio
Castells, Daniel
Correa, Oscar
Figiolino, Pietro
Lanusse, Carlos Edmundo
author2_role author
author
author
author
author
dc.subject.none.fl_str_mv Bioavailability
Efficacy
Ivermectin
Lambs
topic Bioavailability
Efficacy
Ivermectin
Lambs
purl_subject.fl_str_mv https://purl.org/becyt/ford/4.3
https://purl.org/becyt/ford/4
dc.description.none.fl_txt_mv Several oral ivermectin (IVM) formulations for use in sheep are available in the pharmaceutical veterinary market in different countries. All of them are indicated at the same dose rate to treat the gastrointestinal nematodes. However, there is a lack of information on the relative systemic exposure (plasma bioavailability) and clinical efficacy among oral formulations routinely used in sheep. The main goal of the work reported here was to perform a pharmaco-parasitological assessment of three different IVM oral formulations in lambs infected with multiple resistant gastrointestinal nematodes. The comparative drug systemic exposure (IVM plasma concentrations) and nematodicidal efficacies (clinical efficacy) in lambs were determined for a reference (RF) and two different test (T1, T2) IVM oral formulations. One hundred and fifty six (n= 156) healthy Corriedale lambs, naturally infected with multiple resistant gastrointestinal nematodes were allocated into four experimental groups (n=39). Animals in each group received treatment (200 μg/kg) with either the RF, one of the test IVM formulations or were kept as untreated control. Blood samples were collected over 15 days post-treatment (n=8). The IVM plasma concentrations were measured by high performance liquid chromatography with fluorescence detection. The faecal nematode egg count reduction test (FECRT) and evaluation of the clinical efficacy were performed at day 14 post-treatment (n=6), where a predominance of IVM highly resistant nematodes was observed. Results and conclusions Neither the overall kinetic behaviour nor the IVM systemic exposure differed among all the tested oral formulations. Equivalent efficacy results were obtained for the different preparations, with an evident therapeutic failure to control Haemonchus spp. and Teladorsagia circumcincta, which correlates with a high degree of nematode resistance to IVM.
Fil: Suarez, Gonzalo. Universidad de la Republica; Uruguay;
Fil: Alvarez, Luis Ignacio. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico - CONICET - Tandil. Centro de Investigación Veterinaria de Tandil; Argentina;
Fil: Castells, Daniel. Área de Investigación del Secretariado Uruguayo de la Lana; Uruguay;
Fil: Correa, Oscar. Universidad de la Republica; Uruguay;
Fil: Figiolino, Pietro. Universidad de la Republica; Uruguay;
Fil: Lanusse, Carlos Edmundo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico - CONICET - Tandil. Centro de Investigación Veterinaria de Tandil; Argentina;
description Several oral ivermectin (IVM) formulations for use in sheep are available in the pharmaceutical veterinary market in different countries. All of them are indicated at the same dose rate to treat the gastrointestinal nematodes. However, there is a lack of information on the relative systemic exposure (plasma bioavailability) and clinical efficacy among oral formulations routinely used in sheep. The main goal of the work reported here was to perform a pharmaco-parasitological assessment of three different IVM oral formulations in lambs infected with multiple resistant gastrointestinal nematodes. The comparative drug systemic exposure (IVM plasma concentrations) and nematodicidal efficacies (clinical efficacy) in lambs were determined for a reference (RF) and two different test (T1, T2) IVM oral formulations. One hundred and fifty six (n= 156) healthy Corriedale lambs, naturally infected with multiple resistant gastrointestinal nematodes were allocated into four experimental groups (n=39). Animals in each group received treatment (200 μg/kg) with either the RF, one of the test IVM formulations or were kept as untreated control. Blood samples were collected over 15 days post-treatment (n=8). The IVM plasma concentrations were measured by high performance liquid chromatography with fluorescence detection. The faecal nematode egg count reduction test (FECRT) and evaluation of the clinical efficacy were performed at day 14 post-treatment (n=6), where a predominance of IVM highly resistant nematodes was observed. Results and conclusions Neither the overall kinetic behaviour nor the IVM systemic exposure differed among all the tested oral formulations. Equivalent efficacy results were obtained for the different preparations, with an evident therapeutic failure to control Haemonchus spp. and Teladorsagia circumcincta, which correlates with a high degree of nematode resistance to IVM.
publishDate 2013
dc.date.none.fl_str_mv 2013-02-11
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/1829
Suarez, Gonzalo; Alvarez, Luis Ignacio; Castells, Daniel; Correa, Oscar; Figiolino, Pietro; et al.; Relative bioavailability and comparative clinical efficacy of different ivermectin oral formulations in lambs; Biomed Central; BMC Veterinary Research; 9; 27; 11-2-2013; 1-8
1746-6148
url http://hdl.handle.net/11336/1829
identifier_str_mv Suarez, Gonzalo; Alvarez, Luis Ignacio; Castells, Daniel; Correa, Oscar; Figiolino, Pietro; et al.; Relative bioavailability and comparative clinical efficacy of different ivermectin oral formulations in lambs; Biomed Central; BMC Veterinary Research; 9; 27; 11-2-2013; 1-8
1746-6148
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/http://www.biomedcentral.com/1746-6148/9/27
info:eu-repo/semantics/altIdentifier/url/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599275/
info:eu-repo/semantics/altIdentifier/doi/10.1186/1746-6148-9-27
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Biomed Central
publisher.none.fl_str_mv Biomed Central
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842269437278814208
score 13.13397